RASGRF1 and Cognitive impairment: Meanwhile, Rasgrf1 upregulation via miRNA-323-5p inhibition may ameliorate cognitive impairment by promoting synaptic plasticity, providing a potentially valuable and effective therapeutic target for cognitive dysfunction after CCH.